Joel Gelfand, MD
NPI 1710902382 · Dermatology Physician · Philadelphia, PA
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Joel Gelfand, MD is a Dermatology Physician provider in Philadelphia, PA (NPI 1710902382).
Provider details
- NPI number
- 1710902382
- Entity type
- Individual
- Primary specialty
- Dermatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- No
- License
- MD071826L (PA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
291 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 155 | $99 |
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 49 | $2 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 32 | $56 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 22 | $67 |
| Biopsy of Related Skin Growth, First Growth11102 | 20 | $33 |
| Destruction of Skin Growth, 1-14 Growths |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 13 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Risankizumab-Rzaabrand: Skyrizi Pen | 64 | 19 |
| Triamcinolone Acetonide | 30 | 23 |
| Clobetasol Propionate | 27 | 19 |
| Risankizumab-Rzaabrand: Skyrizi | 26 | — |
| Tapinarofbrand: Vtama | 22 | 13 |
| Guselkumabbrand: Tremfya | 20 | — |
| Apremilastbrand: Otezla | 20 | — |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$84,610 across 114 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-07-13
- Last updated
- 2011-02-18
Frequently asked questions
- What is Joel Gelfand's NPI number?
- Joel Gelfand's National Provider Identifier (NPI) is 1710902382, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Joel Gelfand's specialty?
- Joel Gelfand is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
- Where is Joel Gelfand located?
- Joel Gelfand's practice location on file with NPPES is 3400 Spruce Street, Philadelphia, PA 19104.
- What is Joel Gelfand's phone number?
- The practice phone number listed in the NPPES registry for Joel Gelfand is (215) 662-2737.
- Does Joel Gelfand accept Medicare?
- Joel Gelfand is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Joel Gelfand's NPI active?
- Yes — Joel Gelfand's NPI (1710902382) is active in the NPPES registry as of the last update on 2011-02-18.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.